C3.ai (AI) shares crashed more than 23% in premarket trading on Thursday after the company announced mass layoffs and badly missed Wall Street's estimates, leaving analysts to sharply criticize the ...

The Details: C3 AI reported quarterly losses of 40 cents per share, which missed the consensus estimate for losses of 29 cents, according to data from Benzinga Pro. Quarterly revenue came in at $53.26 ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After replacing its founder as ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min C3.ai once rode the AI boom to a ...

Media reports suggest C3.ai intends to merge with Automation Anywhere. The rumors are not confirmed and C3 doesn't look attractive if the merger does not happen. Details on the rumored transaction are ...

Jan 27 (Reuters) - Enterprise artificial intelligence software provider C3.AI (AI.N), opens new tab is in talks to merge with software company Automation Anywhere, The Information reported on Tuesday, ...

LinkedIn's algorithm has changed, making old tactics obsolete. Align your profile with content topics. Prioritize "saves" as the key engagement metric by creating valuable, referenceable content. Post ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

C3.ai, Inc. (NASDAQ: AI) stock is trending ahead of the company’s second-quarter earnings report, which is expected after the market closes. What To Know: Analysts estimate that C3.ai will report an ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of ...

Leadership change follows Siebel stepping down due to health concerns C3 AI's stock down over 54% in 2025 amid financial struggles Ehikian's CEO appointment led to withdrawal of full-year financial ...